Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-08-002633
Filing Date
2008-03-13
Accepted
2008-03-12 21:46:51
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2183627z10-k.htm 10-K 1273434
2 EXHIBIT 21.1 a2183627zex-21_1.htm EX-21.1 3009
3 EXHIBIT 23.1 a2183627zex-23_1.htm EX-23.1 6896
4 EXHIBIT 31.1 a2183627zex-31_1.htm EX-31.1 7305
5 EXHIBIT 31.2 a2183627zex-31_2.htm EX-31.2 7356
6 EXHIBIT 32.1 a2183627zex-32_1.htm EX-32.1 4735
7 G105640.JPG g105640.jpg GRAPHIC 4118
8 G545922.JPG g545922.jpg GRAPHIC 30926
  Complete submission text file 0001047469-08-002633.txt   1352809
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19756 | Film No.: 08684805
SIC: 2836 Biological Products, (No Diagnostic Substances)